Traditional Alternative Medicine Research

Traditional Alternative Medicine Research (TAMR) is a biotechnology company dedicated to the discovery and development of therapeutic agents derived from natural sources. The company specializes in the scientific validation of traditional remedies, most notably through its work with blue scorpion venom extracts. TAMR's lead candidate, Escozine, utilizes a proprietary polarization technology to enhance the efficacy of venom-derived peptides in targeting cancer cells. Beyond oncology, the company is expanding its pipeline to include treatments for viral infections and metabolic disorders. TAMR aims to integrate natural product research with rigorous clinical standards to provide novel solutions for unmet medical needs.